Unique ID issued by UMIN | UMIN000006039 |
---|---|
Receipt number | R000007151 |
Scientific Title | Phase II study of perioperative mFOLFOX plus Panitumumab for stage III rectal cancer |
Date of disclosure of the study information | 2011/07/26 |
Last modified on | 2012/01/31 08:53:03 |
Phase II study of perioperative mFOLFOX plus Panitumumab for stage III rectal cancer
perioperative mFOLFOX plus Panitumumab for stage III rectal cancer
Phase II study of perioperative mFOLFOX plus Panitumumab for stage III rectal cancer
perioperative mFOLFOX plus Panitumumab for stage III rectal cancer
Japan |
rectal cancer
Gastrointestinal surgery |
Malignancy
NO
The aim of this prospective study was to evaluate the efficacy and feasibility of perioperative mFOLFOX plus pamitumumab in patients with stage III rectal cancer.
Efficacy
Response rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
anticancer drags (mFOLFOX6 plus panitumumab)
20 | years-old | <= |
80 | years-old | >= |
Male and Female
Clinically staged T3 N1-2 rectal cancer patients were enrolled in this study.
Previous treatment of rectal cancer
Multiple cancer and/or double cancer
Any severe concurrent medical condition which would make it undesirable
43
1st name | |
Middle name | |
Last name | Mitsuyoshi Ota |
Yokohama City University
Gastroenterological Surgery
3-9 Fukuura, Kanazawa-ku, Yokohama, Japan
1st name | |
Middle name | |
Last name | Mitsuyoshi Ota |
Yokohama City University
Gastroenterological Surgery
m_ota@yokohama-cu.ac.jp
Yokohama City University
Yokohama City University
Self funding
NO
2011 | Year | 07 | Month | 26 | Day |
Unpublished
Open public recruiting
2011 | Year | 07 | Month | 25 | Day |
2011 | Year | 08 | Month | 01 | Day |
2011 | Year | 07 | Month | 25 | Day |
2012 | Year | 01 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007151